Irinotecan Induces Autophagy-Dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells

BACKGROUND: Irinotecan (IRI) is considered an option for second-line treatment of advanced gastric cancer; however, acquired drug resistance currently limits its clinical application. Recently, many researchers have shown that autophagy plays a crucial role in the resistance of tumor cells to chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qingyun, Guo, Yuehui, Chen, Shiwei, Fu, Daiquan, Li, Yanxiang, Li, Zhi, Ni, Caifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135144/
https://www.ncbi.nlm.nih.gov/pubmed/32308415
http://dx.doi.org/10.2147/OTT.S240803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135144/
https://www.ncbi.nlm.nih.gov/pubmed/32308415
http://dx.doi.org/10.2147/OTT.S240803

Ejemplares similares